ENTRY       D12174                      Drug
NAME        Bebtelovimab (USAN);
            Bebtelovimab (TN)
PRODUCT
  OTHER     BEBTELOVIMAB (Eli Lilly and Company)
FORMULA     C6386H9950N1684O2009S42
EXACT_MASS  143717.6461
MOL_WEIGHT  143806.1406
SEQUENCE    (Heavy chain)
            QITLKESGPT LVKPTQTLTL TCTFSGFSLS ISGVGVGWLR QPPGKALEWL ALIYWDDDKR
            YSPSLKSRLT ISKDTSKNQV VLKMTNIDPV DTATYYCAHH SISTIFDHWG QGTLVTVSSA
            STKGPSVFPL APSSKSTSGG TAALGCLVKD YFPEPVTVSW NSGALTSGVH TFPAVLQSSG
            LYSLSSVVTV PSSSLGTQTY ICNVNHKPSN TKVDKRVEPK SCDKTHTCPP CPAPELLGGP
            SVFLFPPKPK DTLMISRTPE VTCVVVDVSH EDPEVKFNWY VDGVEVHNAK TKPREEQYNS
            TYRVVSVLTV LHQDWLNGKE YKCKVSNKAL PAPIEKTISK AKGQPREPQV YTLPPSREEM
            TKNQVSLTCL VKGFYPSDIA VEWESNGQPE NNYKTTPPVL DSDGSFFLYS KLTVDKSRWQ
            QGNVFSCSVM HEALHNHYTQ KSLSLSPGK
            (Light chain)
            QSALTQPASV SGSPGQSITI SCTATSSDVG DYNYVSWYQQ HPGKAPKLMI FEVSDRPSGI
            SNRFSGSKSG NTASLTISGL QAEDEADYYC SSYTTSSAVF GGGTKLTVLG QPKAAPSVTL
            FPPSSEELQA NKATLVCLIS DFYPGAVTVA WKADSSPVKA GVETTTPSKQ SNNKYAASSY
            LSLTPEQWKS HRSYSCQVTH EGSTVEKTVA PTECS
            (Disulfide bridge: H22-H97, H146-H202, H222-L214, H228-H'228, H231-H'231, H263-H323, H369-H427, H'22-H'97, H'146-H'202, H'222-L'214, H'263-H'323, H'369-H'427, L22-L90, L137-L196, L'22-L'90, L'137-L'196)
  TYPE      Peptide
CLASS       Antiviral
             DG03174  Anti-SARS-CoV-2 agent
REMARK      Product: D12174<US>
EFFICACY    Antiviral
  DISEASE   Coronavirus disease 2019 [DS:H02398]
  TYPE      Monoclonal antibody
COMMENT     Treatment of SARS-CoV-2 infection
TARGET      SARS-CoV-2 spike glycoprotein [KO:K24152]
  PATHWAY   ko03230(K24152)  Viral genome structure
            ko05171(K24152)  Coronavirus disease - COVID-19
BRITE       Drug groups [BR:br08330]
             Antiviral
              DG03174  Anti-SARS-CoV-2 agent
               D12174  Bebtelovimab
            Drug classes [BR:br08332]
             Antiviral
              DG03174  Anti-SARS-CoV-2 agent
               D12174  Bebtelovimab
            Antimicrobials [BR:br08307]
             Antivirals
              Entry, fusion or uncoating inhibitor
               Coronavirus spike protein
                D12174  Bebtelovimab (USAN) &lt;US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D12174
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D12174
DBLINKS     CAS: 2578319-11-4
///
